Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study

Sands, Be; Chen, Jj; Feagan, Bg; Penney, M; Rees, Wa; Danese, S; Higgins, Pdr; Newbold, P; Faggioni, R; Patra, K; Li, J; Klekotka, P; Morehouse, C; Pulkstenis, E; Drappa, J; van der Merwe, R; Gasser, Ra